EE9400326A - Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid - Google Patents
Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadidInfo
- Publication number
- EE9400326A EE9400326A EE9400326A EE9400326A EE9400326A EE 9400326 A EE9400326 A EE 9400326A EE 9400326 A EE9400326 A EE 9400326A EE 9400326 A EE9400326 A EE 9400326A EE 9400326 A EE9400326 A EE 9400326A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- pharmaceutical preparations
- preparations containing
- peptide analogues
- opioid peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9300012A SE9300012D0 (sv) | 1993-01-05 | 1993-01-05 | New peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9400326A true EE9400326A (et) | 1996-04-15 |
Family
ID=20388466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9400326A EE9400326A (et) | 1993-01-05 | 1994-11-03 | Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5602099A (cs) |
| EP (1) | EP0678099A1 (cs) |
| JP (1) | JPH08505386A (cs) |
| KR (1) | KR960700269A (cs) |
| CN (1) | CN1096515A (cs) |
| AP (1) | AP508A (cs) |
| AU (1) | AU681372B2 (cs) |
| CA (1) | CA2152380A1 (cs) |
| CZ (1) | CZ171195A3 (cs) |
| EE (1) | EE9400326A (cs) |
| FI (1) | FI953302A (cs) |
| HU (1) | HUT72597A (cs) |
| IL (1) | IL108169A0 (cs) |
| IS (1) | IS4115A (cs) |
| LV (1) | LV10962B (cs) |
| MX (1) | MX9400255A (cs) |
| NO (1) | NO952650L (cs) |
| NZ (1) | NZ259597A (cs) |
| PL (1) | PL309778A1 (cs) |
| SE (1) | SE9300012D0 (cs) |
| SI (1) | SI9400005A (cs) |
| SK (1) | SK83995A3 (cs) |
| WO (1) | WO1994015959A1 (cs) |
| YU (1) | YU394A (cs) |
| ZA (1) | ZA9455B (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU221092B1 (en) * | 1993-12-23 | 2002-08-28 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| IS4261A (is) * | 1994-02-21 | 1995-08-22 | Astra Aktiebolag | Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra |
| IL114046A0 (en) * | 1994-06-20 | 1995-10-31 | Astra Ab | New opioid peptide antagonists |
| US6184208B1 (en) | 1994-06-29 | 2001-02-06 | Immunotech Developments Inc. | Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| RU2067000C1 (ru) * | 1994-06-29 | 1996-09-27 | Владислав Исакович Дейгин | Пептид и способ его получения |
| SE9402880D0 (sv) * | 1994-08-30 | 1994-08-30 | Astra Ab | New peptide derivatives |
| US5780589A (en) * | 1994-11-30 | 1998-07-14 | The United States Of America As Represented By The Department Of Health And Human Services | Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof |
| EP0837857A4 (en) * | 1995-03-29 | 1998-08-05 | Merck & Co Inc | FARNESYL-PROTEIN TRANSFERASE INHIBITORS |
| CA2216532A1 (en) * | 1995-03-29 | 1996-10-31 | S. Jane Desolms | Inhibitors of farnesyl-protein transferase |
| DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
| SE9600769D0 (sv) * | 1996-02-28 | 1996-02-28 | Astra Ab | Compounds useful as analgesic |
| CA2291778A1 (en) * | 1997-05-29 | 1998-12-03 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
| US6306576B1 (en) * | 1999-02-19 | 2001-10-23 | Cleveland Clinic Foundation | Diagnostic methods for asthma |
| US7601739B2 (en) | 2003-08-08 | 2009-10-13 | Virgina Commonwealth University | Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases |
| US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
| US20080045610A1 (en) * | 2004-09-23 | 2008-02-21 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
| JP2008514612A (ja) * | 2004-09-23 | 2008-05-08 | ミシャロウ、アレクサンダー | 対抗適応を誘発することにより神経伝達物質系を調節する方法 |
| WO2015200828A1 (en) * | 2014-06-27 | 2015-12-30 | H. Lee Moffit Cancer Center And Research Institute, Inc. | Conjugates for immunotherapy |
-
1993
- 1993-01-05 SE SE9300012A patent/SE9300012D0/xx unknown
- 1993-12-20 CZ CZ951711A patent/CZ171195A3/cs unknown
- 1993-12-20 KR KR1019950702750A patent/KR960700269A/ko not_active Application Discontinuation
- 1993-12-20 CA CA002152380A patent/CA2152380A1/en not_active Abandoned
- 1993-12-20 JP JP6515914A patent/JPH08505386A/ja active Pending
- 1993-12-20 HU HU9502041A patent/HUT72597A/hu unknown
- 1993-12-20 EP EP94904365A patent/EP0678099A1/en not_active Withdrawn
- 1993-12-20 PL PL93309778A patent/PL309778A1/xx unknown
- 1993-12-20 SK SK839-95A patent/SK83995A3/sk unknown
- 1993-12-20 WO PCT/SE1993/001090 patent/WO1994015959A1/en not_active Application Discontinuation
- 1993-12-20 AU AU58448/94A patent/AU681372B2/en not_active Ceased
- 1993-12-20 NZ NZ259597A patent/NZ259597A/en unknown
- 1993-12-24 IL IL10816993A patent/IL108169A0/xx unknown
- 1993-12-27 IS IS4115A patent/IS4115A/is unknown
-
1994
- 1994-01-04 US US08/176,938 patent/US5602099A/en not_active Expired - Fee Related
- 1994-01-04 MX MX9400255A patent/MX9400255A/es unknown
- 1994-01-05 SI SI9400005A patent/SI9400005A/sl unknown
- 1994-01-05 YU YU394A patent/YU394A/sh unknown
- 1994-01-05 ZA ZA9455A patent/ZA9455B/xx unknown
- 1994-01-05 CN CN94100129A patent/CN1096515A/zh active Pending
- 1994-01-05 AP APAP/P/1994/000605A patent/AP508A/en active
- 1994-11-03 EE EE9400326A patent/EE9400326A/xx unknown
-
1995
- 1995-06-29 LV LVP-95-197A patent/LV10962B/en unknown
- 1995-07-04 NO NO952650A patent/NO952650L/no not_active Application Discontinuation
- 1995-07-04 FI FI953302A patent/FI953302A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ259597A (en) | 1996-07-26 |
| PL309778A1 (en) | 1995-11-13 |
| IL108169A0 (en) | 1994-04-12 |
| FI953302A0 (fi) | 1995-07-04 |
| LV10962A (lv) | 1995-12-20 |
| KR960700269A (ko) | 1996-01-19 |
| AU5844894A (en) | 1994-08-15 |
| AP9400605A0 (en) | 1994-01-31 |
| WO1994015959A1 (en) | 1994-07-21 |
| CN1096515A (zh) | 1994-12-21 |
| SK83995A3 (en) | 1996-09-04 |
| CZ171195A3 (en) | 1996-09-11 |
| CA2152380A1 (en) | 1994-07-21 |
| YU394A (sh) | 1997-07-31 |
| ZA9455B (en) | 1994-07-05 |
| NO952650L (no) | 1995-08-30 |
| LV10962B (en) | 1997-04-20 |
| HUT72597A (en) | 1996-05-28 |
| AP508A (en) | 1996-07-22 |
| SI9400005A (en) | 1994-12-31 |
| SE9300012D0 (sv) | 1993-01-05 |
| US5602099A (en) | 1997-02-11 |
| AU681372B2 (en) | 1997-08-28 |
| NO952650D0 (no) | 1995-07-04 |
| FI953302A (fi) | 1995-07-04 |
| MX9400255A (es) | 1994-07-29 |
| JPH08505386A (ja) | 1996-06-11 |
| HU9502041D0 (en) | 1995-09-28 |
| IS4115A (is) | 1994-07-06 |
| EP0678099A1 (en) | 1995-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9400455A (et) | Peptiidi derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine | |
| EE9400326A (et) | Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid | |
| EE04375B1 (et) | Modifitseeritud aminohapped, neid ühendeid sisaldavad ravimid ja nende valmistamise meetod | |
| DE3266354D1 (en) | Possibly protected peptides, process for their preparation and pharmaceutical agents containing them | |
| IL106600A0 (en) | Peptides,pharmaceutical compositions containing the same and processes for the preparation thereof | |
| EE03111B1 (et) | Glükokortikosteroidi epimeerid, nende valmistamise protsessid ja neid sisaldavad ravimpreparaadid | |
| EE04021B1 (et) | 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks | |
| GB9113219D0 (en) | Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same | |
| FI954767A (fi) | Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus | |
| IL85136A0 (en) | Peptide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL103612A0 (en) | Peptides,their preparation and pharmaceutical compositions containing them | |
| EE200000380A (et) | 11ß-halogeno-7(alfa)-asendatud östratrieenid, neid 11ß-halogeno-7(alfa)-asendatud östratrieene sisaldavate farmatseutiliste preparaatide valmistamise meetodid ja nende kasutamine ravimite valmistamiseks | |
| EE03110B1 (et) | Steroidi estrid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid | |
| IT8647666A0 (it) | Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti | |
| NO982874D0 (no) | Farmas°ytiske preparater med vitamin D-analoger | |
| AU7428691A (en) | Long-acting liposome peptide pharmaceutical products and processes for the preparation thereof | |
| NZ234268A (en) | Vasoactive intestinal peptide analogues, derivatives and pharmaceutical compositions | |
| FI961938A (fi) | Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
| IL92268A0 (en) | 14alpha,17alpha,ethanoestratriene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| EE9400148A (et) | Tienotiasiini derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised preparaadid | |
| IL96216A0 (en) | Peptide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL99389A0 (en) | Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IT8748235A0 (it) | Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti | |
| NO951350D0 (no) | Farmasöytiske preparater inneholdende 3-substituerte 2-oksindol-1-karboksamider | |
| FI940717A (fi) | Streptogramiinien puhdistetut muodot, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet |